IMMUNOVANT, INC. Cash Flow Charts

4 quarters of history · ending 2024-03-31 · SEC EDGAR

Source:10-K · 10-Q

Capital Allocation

How management deploys cash: investing in the business (Capex + M&A) vs returning to shareholders (Buybacks + Dividends).

Capital Allocation Waterfall

Buybacks vs Stock-Based Comp

Cash Flow

Cash Flow by Activity

Operating Cash Flow
$-47M
Free Cash Flow
$-150K
Investing Cash Flow
$-45K
Financing Cash Flow
$2M
Capex
$150K
Stock-Based Comp
$10M
D&A
$64K
SBC Allocated Expense
$10M